- This event has passed.
March 10, 2020 @ 6:00 pm - 7:30 pm
Providence Health Care Research Institute, BC Children’s Hospital Research Institute and Vancouver Coastal Health Research Institute invite you to an informative talk and Q&A panel to learn more about cutting-edge research on the prevention, treatment and management of chronic illnesses.
Attendance is FREE but space is limited, so please register for the event.
Light refreshments will be provided.
When: Tuesday, March 10 | 6:00 – 7:30pm (doors open at 5:30pm)
Where: St. Paul’s Hospital (Cullen Family Lecture Theatre) | 1081 Burrard St., Vancouver
Download directions to the Cullen Family Lecture Theatre
Questions? Email research@providencehealth.bc.ca
More about the speakers:
Dr. Kelly Brown
Presentation title: “Chronic Pediatric Vasculitis: Using gaps in clinical care to guide translational research and improve outcomes for complex rheumatic diseases of childhood.”
Dr. Brown is a research scientist with an interest in chronic rheumatic and inflammatory conditions, especially those that develop in childhood. She received her early academic training in Canada, studying biochemistry (B.Sc.) at Simon Fraser University and immunology (Ph.D.) at the University of British Columbia (UBC). She went on to do postdoctoral training at the Wellcome Trust Sanger Institute in the United Kingdom and at The University of Gothenburg in Sweden. In 2014, she became the first scientist to be appointed to the UBC Division of Rheumatology at the BC Children’s Hospital. Her research program aims to find biologic measures of immune activation in order to improve assessment and management of chronic childhood rheumatic diseases. www.kbrownlab.ca
Dr. Silke Cresswell
Presentation title: “From microbes to movement, a systems approach to brain health.”
Dr. Cresswell is a movement disorder neurologist and clinician scientist at the UBC Movement disorder clinic at the Djavad Mowafaghian Centre for Brain Health and active staff at Vancouver General Hospital. With a strong athletic background, her clinical and research work focuses on a holistic, interdisciplinary approach to the treatment and prevention of brain disorders. Complementary to typical medical treatments, interventions target physical and emotional well-being through active engagement in exercise, art, mindfulness, nutrition, enjoying nature and community building. She is investigating the role of the gut microbiome with the goal to find new approaches to neurodegenerative disorders. In addition to Parkinson’s disease, dystonia is a particular interest of her work. She serves as president of the Canadian Movement Disorder Group, as the director of the annual National Canadian Neurology Residents Course for Movement Disorders, and is co-founder and director of the BC Brain Wellness Foundation.
Dr. Kelly McNagny
Presentation title: Early life exposures that influence adult chronic disease
Dr. McNagny obtained his PhD in Immunology at the U of Alabama at Birmingham (1990) with Dr. Max D Cooper (National Academy of Sciences) studying proteins that regulate B cell maturation and homing. He then performed postdoctoral training with Dr. Thomas Graf (1991-98, European Molecular Biology Laboratory, Heidelberg) studying transcriptional control of stem cell maturation and fate. In 1998 he started his own laboratory at the University of British Columbia focused on stem cell behavior, innate immune responses, inflammatory disease, cancer biology and therapeutics. He is a Professor in the Departments of Medical Genetics and Biomedical Engineering and a Member of the Centre for Heart Lung Innovation. Nationally, he fills leadership roles in the Stem Cell Network Centre of Excellence (Trainee Education Committee), and is Associate Scientific Director of the Canadian AllerGen Network Centre of Excellence.
More about our host:
Dr. Darryl Knight
Dr. Darryl Knight joined Providence Health Care as Vice-President, Research and Academic Affairs in 2019. His role also includes accountabilities as President, Providence Health Care Research Institute; Professor, Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia; and Associate Dean, Research, Faculty of Medicine, UBC. Dr. Knight obtained his PhD from the University of Western Australia in 1993. In 2004, he was recruited to UBC as the Canada Research Chair in Airway Disease. He was recruited back to Australia in 2013 and was Professor and Head of School of Biomedical Sciences and Pharmacy at the University of Newcastle. Continuing this pattern, Dr. Knight was recruited back to Canada in 2019 taking up his current role.
Event contact: research@providencehealth.bc.ca
